Completed

A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Zingiber Officinale Roscoe Extract on Body Fat

What is being tested

Zingiber officinale Roscoe extract 200 mg

+ Placebo

Dietary Supplement

Who is being recruted

Body Weight+5

+ Nutrition Disorders

+ Nutritional and Metabolic Diseases

From 19 to 65 Years

+9 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Prevention Study

Placebo-Controlled

Interventional

Study Start: February 2017

See protocol details

Summary

Principal SponsorChonbuk National University Hospital

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: February 3, 2017

Actual date on which the first participant was enrolled.

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Forty subjects were randomly divided into Zingiber officinale Roscoe extract 200 mg or placebo group. The investigators measured Body Fat Mass, Percent Body Fat, Fat Free Mass, weight, and body mass index.

Official TitleA 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Zingiber Officinale Roscoe Extract on Body Fat

NCT03260751

Principal SponsorChonbuk National University Hospital

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

80 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 19 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Body WeightNutrition DisordersNutritional and Metabolic DiseasesObesitySigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionOverweight

Criteria

3 inclusion criteria required to participate

age between 19 and 65 years,

BMI 25~29.9 kg/m2

subjects giving written informed consent

6 exclusion criteria prevent from participating

Significant variation in weight(more 10%) in the past 3 months

Cardiovascular disease, e.g. arrhythmia, heart failure, myocardial infarction, and patient with pacemaker

History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease or gastrointestinal surgery

Participation in any other clinical trials within past 2 months

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental

2 cap/day, 800 mg/cap for 12 weeks

Group II

Placebo

Placebo for 12 weeks

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Clinical Trial Center for Functional Foods Chonbuk National University Hospital

Jeonju, South KoreaOpen Clinical Trial Center for Functional Foods Chonbuk National University Hospital in Google Maps

CompletedOne Study Center